WHAT’S UP WITH FLU IN ’22! SURVEILLANCE, VACCINES, POLICY, AND COMMUNICATIONS LAST YEAR AND NEXT

May 20, 2022

Moderator
L.J Tan, MS, PhD 
Chief Policy and Partnerships Officer
Immunize.org (formerly Immunization Action Coalition)
Co-chair, National Adult and Influenza Immunization Summit

SESSION ONE: Opening welcome

Video: Session One

• CDC Welcome
  Shannon Stokley, DrPhD
  Deputy Division Director
  Office of the Director (OD), Immunization Services Division, NCIRD

• OIDP, HHS Welcome
  David Kim, MD, MA
  CAPT, U.S. Public Health Service Director, Division of Vaccines
  U.S. Dept. of Health and Human Services (HHS), Office of Infectious Disease and HIV/AIDS Policy (OIDP), Office of the Assistant Secretary for Health (OASH)

• Immunize.org Welcome
  Kelly L. Moore, MD, MPH
  President and Chief Executive Officer
  Immunize.org (formerly Immunization Action Coalition)
  

SESSION Two: influenza season summaries for 2022–23

Video: Session Two

 

• The Return of Influenza (A Summary of 2021–2022 Influenza Season)
  Alicia Budd, MPH (View Slides)
  Influenza Division
  NCIRD, CDC

• Updates on Influenza Vaccine Effects (View Slides)
  Alicia M. Fry, MD, MPH
  Chief, Epidemiology and Prevention Branch
  NCIRD, CDC

• Influenza Vaccination Coverage: Preliminary Estimates for the 2021–2022 Season (Slides not posted per presenter’s request.)
  Carla Black, PhD 
  Assessment Branch
  Immunization Services Division

SESSION Three: Partnering for Vaccine Equity to reduce hesitancy and disparities in vaccine uptake

Video: Session Three

 

• Chelsea Toledo, MA, MPH (moderator) (View Slides)
  Public Health Advisor
  Immunization Services Division-NCIRD

• The 2022 Influenza Vaccine Landscape & Urban AI/AN Communities (View Slides)
  Andrew Kalweit, MPH 
  Director of Research and Public Health Program
  National Council of Urban Indian Health
  Tiffani Stark, MHA
  Public Health Program Manager
  National Council of Urban Indian Health

• Wellness Warriors
  Meg Jordan, MPH
  Coordinator
  Maryland Center for Health Equity

SESSION Four: ACIP Influenza Update

Video: Session Four

 

• ACIP Influenza Update 
  Lisa Grohskopf, MD, MPH
  Influenza Division
  NCIRD, CDC

Question and Answer segment

Video: Questions and Answers

SESSION Five: Influenza Vaccines in development

Video: Session Five

 

• Influenza Vaccines in Development (View Slides)
  Phyllis Arthur, MBA 
  Vice President, Infectious Diseases and Diagnostic Policy
  BIO

SESSION six: Manufacturers panel discussion plus estimates of 2022-2023 influenza vaccine supply

• L.J Tan, MS, PhD (moderator)
  Chief Policy and Partnerships Officer
  Immunize.org (formerly Immunization Action Coalition)
  Co-chair, National Adult and Influenza Immunization Summit

Panel Discussion 

• Meaghan Pettengill
  Director, Public Customer Strategy and Engagement, U.S. Infectious Diseases (COVID-19 & Flu)
  AstraZeneca Pharmaceuticals LP
• Adam Lane
  Director, Retail Trade Strategy, U.S. Vaccines 
  Pharma North America, GSK
• David Ross
  Vice President of Commercial Operations – North America
  Seqirus
• Julian Ritchey
  VP, Head of Public Affairs and Patient Advocacy, U.S. Vaccines
  Sanofi Pasteur

SESSION seven: 2021-2022 & 2022-2023 Influenza Vaccination Campaign

Video: Session Seven

 

• Erin Burns, MA
  Associated Director for Communications Science 
  Influenza Division, CDC
• Elizabeth (Bess) Davenport, MPH 
  Influenza Flu Vaccine Campaign Team
  NCIRD

SESSION eight: Closing

• L.J Tan, MS, PhD
  Chief Policy and Partnerships Officer
  Immunize.org (formerly Immunization Action Coalition)
  Co-chair, National Adult and Influenza Immunization Summit